FDA Approves mRNA COVID Shots in Babies

Jun 20, 2022

WASHINGTON, D.C. – On June 17, 2022, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for mRNA COVID shots to be injected into babies as young as six months of age. All this despite the evidence that these shots are not safe or effective for babies and toddlers. Nor are they necessary for this young age. 

For the Moderna COVID-19 injection, the FDA amended the EUA to include use of the vaccine in individuals 6 months through 17 years of age. The vaccine had been authorized for use in adults 18 years of age and older. For the Pfizer-BioNTech COVID-19 Vaccine, the FDA amended the EUA to include use of the vaccine in individuals 6 months through 4 years of age. The vaccine had been authorized for use in individuals 5 years of age and older. 

The announcement came just two days after the FDA Vaccines and Related Biological Products Advisory Committee voted unanimously to recommend that the agency authorize the mRNA COVID injections for children under five years of age and as young as six months. Previously, only children five years of age and older were allowed to get jabbed, and only with the Pfizer injection, while people 18 years of age and older were allowed to take Moderna. Now, infants can have their DNA permanently destroyed with either brand, thanks to the FDA. 

Then on June 18, the Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, endorsed the Advisory Committee on Immunization Practices’ recommendation that all children six months through five years of age should receive a COVID-19 shot.

Research shows that there is no benefit to children receiving a COVID shot and the injections can cause potential harm, adverse effects and death. According to Pfizer’s own study trial data, the chance of death in children from the shot is 107 times higher than death from COVID. 

In addition, an analysis by two Israeli researchers shows that at least 58 life-threatening adverse events from the shots in infants and toddlers under three years old were reported to VAERS. The most common serious adverse events were life-threatening bleeding, anaphylactic shock, anticholinergic syndrome, encephalitis, hypoglycemia and neuroleptic syndrome. In most of the reported cases, these children had multiple injuries. During the analysis, cases were removed in which it was stated that the exposure to the COVID shot was through breastfeeding. 

The FDA’s briefing document released before the FDA’s committee meeting last week claimed that the vaccine efficacy in children under five years is 80.3 percent. However, even though the study to “determine” this included 1,678 children who received three doses of the formulation, the stated 80.3 percent efficacy claim is based only on “10 symptomatic COVID-19 cases identified from seven days after the third dose and accrued as of April 29, 2022” (emphasis added). 

A recent study also suggests that the effectiveness of COVID-19 shots in children is low in the beginning and wanes rapidly to statistical insignificance. Moreover, the data suggests that vaccine effectiveness in children actually becomes negative within several months after the second dose. 

Liberty Counsel Founder and Chairman Mat Staver said, “There is no significant benefit and all risk to inject a baby with an experimental COVID shot. The FDA has discredited itself.” 

Liberty Counsel provides broadcast quality TV interviews via Hi-Def Skype and LTN at no cost.

TAKE ACTION